Act 3: The Stacking Question What Longevity Experts Say About Combining Both The most sophisticated practitioners in the longevity space don't typically ask, "Should I use GLP-1 or BPC-157?" Instead, they ask, "When does each one belong in a protocol, and can they safely coexist?" The Complementary Logic Longevity-focused physicians and sports medicine practitioners have begun articulating a clear rationale for combining these compounds in specific patient profiles: The GLP-1 Layer: Addresses the metabolic side (reducing fat, improving insulin, lowering cardiovascular risk)
This disease is characterized by several symptoms such as depressed mood, lack of interest or pleasure, fatigue, loss of energy, sleep disturbance, anxiety, and neurocognitive and sexual dysfunction, being highly debilitating
Since GSH-dependent redox reactions require the glutathionylated intermediate, we explain the lack of efficient oxidoreductase activity on glutathionylated substrates by a different GSH binding mode that possibly inflicts strain on the disulfide between ROXY9 and glutathione
Finally, cell lysate was additionally homogenised by dispensing the lysate 10 times using a G26 needle and syringe
